tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NRx Pharmaceuticals re-files abbreviated NDA for KETAFR
PremiumThe FlyNRx Pharmaceuticals re-files abbreviated NDA for KETAFR
15d ago
NRX Pharmaceuticals Gains FDA Approval for KETAFREE™
Premium
Company Announcements
NRX Pharmaceuticals Gains FDA Approval for KETAFREE™
18d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine Product
20d ago
NRX Pharmaceuticals Raises $8.8 Million in Stock Offering
PremiumCompany AnnouncementsNRX Pharmaceuticals Raises $8.8 Million in Stock Offering
1M ago
NRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
Premium
The Fly
NRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
1M ago
NRx Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
NRx Pharmaceuticals initiated with a Buy at H.C. Wainwright
1M ago
NRx Pharmaceuticals announces expanded access policy for NRX-100
PremiumThe FlyNRx Pharmaceuticals announces expanded access policy for NRX-100
2M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
2M ago
NRx Pharmaceuticals price target raised to $25 from $21 at BTIG
Premium
The Fly
NRx Pharmaceuticals price target raised to $25 from $21 at BTIG
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100